Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Tóm tắt
In past two decades poly lactic-co-glycolic acid (PLGA) has been among the most attractive polymeric candidates used to fabricate devices for drug delivery and tissue engineering applications. PLGA is biocompatible and biodegradable, exhibits a wide range of erosion times, has tunable mechanical properties and most importantly, is a FDA approved polymer. In particular, PLGA has been extensively studied for the development of devices for controlled delivery of small molecule drugs, proteins and other macromolecules in commercial use and in research. This manuscript describes the various fabrication techniques for these devices and the factors affecting their degradation and drug release.
Từ khóa
Tài liệu tham khảo
Bouissou, 2006, The influence of surfactant on PLGA microsphere glass transition and water sorption: Remodeling the surface morphology to attenuate the burst release, Pharm. Res., 23, 1295, 10.1007/s11095-006-0180-2
Jain, 2000, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, 21, 2475, 10.1016/S0142-9612(00)00115-0
Ruhe, 2003, rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites, J. Bone Jt. Surg., 85, 75, 10.2106/00004623-200300003-00013
Allison, 2008, Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic)acid microparticle drug delivery systems, J. Pharm. Sci., 97, 2022, 10.1002/jps.21124
Mundargi, 2008, Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives, J. Control. Release, 125, 193, 10.1016/j.jconrel.2007.09.013
Mohamed, 2008, Engineering biodegradable polyester particles with specific drug targeting and drug release properties, J. Pharm. Sci., 97, 71, 10.1002/jps.21082
Uhrich, 1999, Polymeric systems for controlled drug release, Chem. Rev., 99, 3181, 10.1021/cr940351u
Nair, 2007, Biodegradable polymers as biomaterials, Prog. Polym. Sci., 32, 762, 10.1016/j.progpolymsci.2007.05.017
Anderson, 1997, Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv. Drug Deliv. Rev., 28, 5, 10.1016/S0169-409X(97)00048-3
Wu, 2001, Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers. Part II: Biodegradation, J. Biomater. Sci. Polym. Ed., 12, 21, 10.1163/156856201744425
Houchin, 2009, Physical properties of PLGA films during polymer degradation, J. Appl. Polym. Sci., 114, 2848, 10.1002/app.30813
Siegel, 2006, Effect of drug type on the degradation rate of PLGA matrices, Eur. J. Pharm. Biopharm., 64, 287, 10.1016/j.ejpb.2006.06.009
Passerini, 2001, An investigation into the effects of residual water on the glass transition temperature of polylactide microspheres using modulated temperature DSC, J. Control. Release, 73, 111, 10.1016/S0168-3659(01)00245-0
Yang, 2001, Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method, Biomaterials, 22, 231, 10.1016/S0142-9612(00)00178-2
Panagi, 2001, Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles, Int. J. Pharm., 221, 143, 10.1016/S0378-5173(01)00676-7
Bazile, 1992, Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats, Biomaterials, 13, 1093, 10.1016/0142-9612(92)90142-B
Esmaeili, 2008, PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution, Int. J. Pharm., 349, 249, 10.1016/j.ijpharm.2007.07.038
Cheng, 2007, Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery, Biomaterials, 28, 869, 10.1016/j.biomaterials.2006.09.047
Li, 2001, PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats, J. Control. Release, 71, 203, 10.1016/S0168-3659(01)00218-8
Ghahremankhani, 2007, PLGA-PEG-PLGA tri-block copolymers as an in-situ gel forming system for calcitonin delivery, Polym. Bull., 59, 637, 10.1007/s00289-007-0807-4
Jeong, 2000, In situ gelation of PEGPLGAPEG triblock copolymer aqueous solutions and degradation thereof, J. Biomed. Mater. Res., 50, 171, 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
Tobio, 1998, Stealth PLA-PEG nanoparticles as protein carriers for nasal administration, Pharm. Res., 15, 270, 10.1023/A:1011922819926
Dhar, 2008, Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles, Proc. Natl. Acad. Sci USA, 105, 17356, 10.1073/pnas.0809154105
Yoo, 2004, Folate receptor targeted biodegradable polymeric doxorubicin micelles, J. Control. Release, 96, 273, 10.1016/j.jconrel.2004.02.003
Duvvuri, 2005, Development of a novel formulation containing poly (D,L-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir, J. Control. Release, 108, 282, 10.1016/j.jconrel.2005.09.002
Garinot, 2007, PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination, J. Control. Release, 120, 195, 10.1016/j.jconrel.2007.04.021
Danhier, 2009, Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation, J. Control. Release, 133, 11, 10.1016/j.jconrel.2008.09.086
Pai, 2009, Poly(ethylene glycol)-modified proteins: Implications for poly(lactide-co-glycolide)-based microsphere delivery, AAPS J., 11, 88, 10.1208/s12248-009-9081-8
Choi, 2002, Synthesis and characterization of elastic PLGA/PCL/PLGA tri-block copolymers, J. Biomater. Sci. Polym. Ed., 13, 1163, 10.1163/156856202320813864
Dong, 2005, In vitro degradation and controlled release behavior of D, L-PLGA50 and PCL-bD, L-PLGA50 copolymer microspheres, J. Control. Release, 107, 53, 10.1016/j.jconrel.2005.05.024
Houchin, 2008, Chemical degradation of peptides and proteins in PLGA: A review of reactions and mechanisms, J. Pharm. Sci., 97, 2395, 10.1002/jps.21176
Arshady, 1991, Preparation of biodegradable microspheres and microcapsules: 2. Polyactides and related polyesters, J. Control. Release, 17, 1, 10.1016/0168-3659(91)90126-X
King, 2000, Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly (D,L-lactic-co-glycolic acid)/poly (ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique, J. Biomed. Mater. Res. Part A, 51, 383, 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
Rosca, 2004, Microparticle formation and its mechanism in single and double emulsion solvent evaporation, J. Control. Release, 99, 271, 10.1016/j.jconrel.2004.07.007
Sah, 1997, Microencapsulation techniques using ethyl acetate as a dispersed solvent: Effects of its extraction rate on the characteristics of PLGA microspheres, J. Control. Release, 47, 233, 10.1016/S0168-3659(97)01647-7
Chaisri, 2009, Preparation and characterization of cephalexin loaded PLGA microspheres, Curr. Drug Deliv., 6, 69, 10.2174/156720109787048186
Mao, 2007, Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres, Int. J. Pharm., 334, 137, 10.1016/j.ijpharm.2006.10.036
Thomasin, 1998, Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 1. Overview and theoretical considerations, J. Pharm. Sci., 87, 259, 10.1021/js970047r
Thomasin, 1998, Drug microencapsulation by PLA/PLGA coacervation in the light of thermodynamics. 2. Parameters determining microsphere formation, J. Pharm. Sci., 87, 269, 10.1021/js970048j
Edelman, 1993, Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide), Vaccine, 11, 155, 10.1016/0264-410X(93)90012-M
Hua, 2002, Macroporous poly(L-lactide) scaffold 1. Preparation of a macroporous scaffold by liquid-liquid phase separation of a PLLA-dioxane-water system, J. Biomed. Mater. Res., 63, 161, 10.1002/jbm.10121
Hua, 2003, A facile preparation of highly interconnected macroporous poly(D,L-lactic acid-co-glycolic acid) (PLGA) scaffolds by liquid-liquid phase separation of a PLGA-dioxane-water ternary system, Polymer, 44, 1911, 10.1016/S0032-3861(03)00025-9
Graham, 1999, Phase inversion dynamics of PLGA solutions related to drug delivery, J. Control. Release, 58, 233, 10.1016/S0168-3659(98)00158-8
Mu, 2001, Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers, J. Control. Release, 76, 239, 10.1016/S0168-3659(01)00440-0
Gavini, 2004, PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: In vitro/in vivo studies, Eur. J. Pharm. Biopharm., 57, 207, 10.1016/j.ejpb.2003.10.018
Nie, 2008, PLGA/chitosan composites from a combination of spray drying and supercritical fluid foaming techniques: New carriers for DNA delivery, J. Control. Release, 129, 207, 10.1016/j.jconrel.2008.04.018
Wagenaar, 1994, Piroxicam release from spray-dried biodegradable microspheres, Biomaterials, 15, 49, 10.1016/0142-9612(94)90196-1
Sastre, 2007, 5-Fluorouracil plasma levels and biodegradation of subcutaneously injected drug-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers, Int. J. Pharm., 338, 180, 10.1016/j.ijpharm.2007.02.001
Castelli, 1996, Effect of molecular weight and storage times on tolmetin release from poly-lactide microspheres to lipid model membrane. A calorimetric study, J. Control. Release, 40, 277, 10.1016/0168-3659(95)00195-6
Barrero, 2007, Micro- and nanoparticles via capillary flows, Annu. Rev. Fluid Mech., 39, 89, 10.1146/annurev.fluid.39.050905.110245
Freitas, 2005, Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microsphere preparation process technology, J. Control. Release, 102, 313, 10.1016/j.jconrel.2004.10.015
Berkland, 2004, Uniform double-walled polymer microspheres of controllable shell thickness, J. Control. Release, 96, 101, 10.1016/j.jconrel.2004.01.018
Loscertales, 2002, Micro/Nano encapsulation via electrified coaxial liquid jets, Science, 295, 1695, 10.1126/science.1067595
Hans, 2002, Biodegradable nanoparticles for drug delivery and targeting, Curr. Opin. Solid State Mater. Sci., 6, 319, 10.1016/S1359-0286(02)00117-1
Lamprecht, 2000, Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique, Int. J. Pharm., 196, 177, 10.1016/S0378-5173(99)00422-6
Murakami, 1999, Preparation of poly(D,L-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method, Int. J. Pharm., 187, 143, 10.1016/S0378-5173(99)00187-8
Konan, 2003, Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy, Eur. J. Pharm. Biopharm., 55, 115, 10.1016/S0939-6411(02)00128-5
Kwon, 2001, Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method, Colloids Surf. A Physicochem. Eng. Asp., 182, 123, 10.1016/S0927-7757(00)00825-6
Rabin, 2008, In vitro and in vivo demonstration of risperidone implants in mice, Schizophr. Res., 98, 66, 10.1016/j.schres.2007.08.003
Widmer, 1998, Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration, Biomaterials, 19, 1945, 10.1016/S0142-9612(98)00099-4
Wang, 2010, A rapid method for creating drug implants: Translating laboratory-based methods into a scalable manufacturing process, J. Biomed. Mater. Res. Part B Appl. Biomater., 93, 562, 10.1002/jbm.b.31617
Yang, 2005, Microfabrication of biodegradable (PLGA) honeycomb-structures and potential applications in implantable drug delivery, Sens. Actuat. B Chem., 106, 506, 10.1016/j.snb.2004.07.017
Grayson, 2005, Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance, Biomaterials, 26, 2137, 10.1016/j.biomaterials.2004.06.033
Stubbe, 2004, “Programmed polymeric devices” for pulsed drug delivery, Pharm. Res., 21, 1732, 10.1023/B:PHAM.0000045223.45400.01
Grayson, 2003, Multi-pulse drug delivery from a resorbable polymeric microchip device, Nat. Mater., 2, 767, 10.1038/nmat998
Koushik, 2004, Preparation of large porous Deslorelin-PLGA microparticles with reduced residual solvent and cellular uptake using a supercritical carbon dioxide process, Pharm. Res., 21, 524, 10.1023/B:PHAM.0000019308.25479.a4
Davies, 2008, Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering, Adv. Drug Deliv. Rev., 60, 373, 10.1016/j.addr.2006.12.001
Hile, 2000, Active growth factor delivery from poly (D,L-lactide-co-glycolide) foams prepared in supercritical CO2, J. Control. Release, 66, 177, 10.1016/S0168-3659(99)00268-0
Xu, 2010, Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging, Biomaterials, 31, 1716, 10.1016/j.biomaterials.2009.11.052
Zhang, 2010, Multifunctional microbubbles for image-guided antivascular endothelial growth factor therapy, J. Biomed. Opt., 15, 030515, 10.1117/1.3457669
Sun, 2008, Multifunctional poly(D,L-lactide-co-glycolide)/ montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer, Biomaterials, 29, 475, 10.1016/j.biomaterials.2007.09.038
Ramchandani, 1998, In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants, J. Control Release, 54, 167, 10.1016/S0168-3659(97)00113-2
Amann, 2010, In vitro-in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia, Pharm. Res., 27, 1730, 10.1007/s11095-010-0152-4
Faisant, 2002, PLGA-based microparticles: Elucidation of mechanisms and a new, simple mathematical model quantifying drug release, Eur. J. Pharm. Sci., 15, 355, 10.1016/S0928-0987(02)00023-4
Crotts, 1998, Protein delivery from poly (lactic-co-glycolic acid) biodegradable microspheres: Release kinetics and stability issues, J. Microencapsul., 15, 699, 10.3109/02652049809008253
Kranz, 2000, Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states, J. Pharm. Sci., 89, 1558, 10.1002/1520-6017(200012)89:12<1558::AID-JPS6>3.0.CO;2-8
Lu, 2000, In vitro and in vivo degradation of porous poly(-lactic-co-glycolic acid) foams, Biomaterials, 21, 1837, 10.1016/S0142-9612(00)00047-8
Lu, 1999, In vitro degradation of thin poly(D,L-lactic-co-glycolic acid) films, J. Biomed. Mater. Res., 46, 236, 10.1002/(SICI)1097-4636(199908)46:2<236::AID-JBM13>3.0.CO;2-F
Park, 1995, Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition, Biomaterials, 16, 1123, 10.1016/0142-9612(95)93575-X
Alexis, 2005, Factors affecting the degradation and drug-release mechanism of poly (lactic acid) and poly [(lactic acid)-co-(glycolic acid)], Polym. Int., 54, 36, 10.1002/pi.1697
Tsuji, 2000, Properties and morphology of poly(L-lactide). III. Effects of initial crystallinity on long-term in vitro hydrolysis of high molecular weight poly(L-lactide) film in phosphate-buffered solution, J. Appl. Polym. Sci., 77, 1452, 10.1002/1097-4628(20000815)77:7<1452::AID-APP7>3.0.CO;2-S
Schliecker, 2003, Hydrolytic degradation of poly(lactide-co-glycolide) films: Effect of oligomers on degradation rate and crystallinity, Int. J. Pharm., 266, 39, 10.1016/S0378-5173(03)00379-X
Park, 1994, Degradation of poly (D,L-lactic acid) microspheres: Effect of molecular weight, J. Control. Release, 30, 161, 10.1016/0168-3659(94)90263-1
Liggins, 2001, Paclitaxel loaded poly(L-lactic acid) microspheres: Properties of microspheres made with low molecular weight polymers, Int. J. Pharm., 222, 19, 10.1016/S0378-5173(01)00690-1
Frank, 2005, Controlled release from bioerodible polymers: Effect of drug type and polymer composition, J. Control. Release, 102, 333, 10.1016/j.jconrel.2004.10.019
Witt, 2001, Morphological characterization of microspheres, films and implants prepared from poly(lactide-co-glycolide) and ABA triblock copolymers: Is the erosion controlled by degradation, swelling or diffusion?, Eur. J. Pharm. Biopharm., 51, 171, 10.1016/S0939-6411(01)00130-8
Grizzi, 1995, Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence, Biomaterials, 16, 305, 10.1016/0142-9612(95)93258-F
Holy, 1999, In vitro degradation of a novel poly(lactide-co-glycolide) 75/25 foam, Biomaterials, 20, 1177, 10.1016/S0142-9612(98)00256-7
Zolnik, 2007, Effect of acidic pH on PLGA microsphere degradation and release, J. Control. Release, 122, 338, 10.1016/j.jconrel.2007.05.034
Cai, 2003, Enzymatic degradation behavior and mechanism of poly(lactide-co-glycolide) foams by trypsin, Biomaterials, 24, 629, 10.1016/S0142-9612(02)00377-0
Li, 2000, Enzymatic degradation of polylactide stereocopolymers with predominant -lactyl contents, Polym. Degrad. Stab., 71, 61, 10.1016/S0141-3910(00)00152-X
Eniola, 2005, Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: Effect of degradation on targeting activity, Biomaterials, 26, 661, 10.1016/j.biomaterials.2004.03.003
Dailey, 2006, Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung, Toxicol. Appl. Pharmacol., 215, 100, 10.1016/j.taap.2006.01.016
Sundback, 2005, Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material, Biomaterials, 26, 5454, 10.1016/j.biomaterials.2005.02.004
Olivier, 1999, Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity, Pharm. Res., 16, 1836, 10.1023/A:1018947208597
Berchane, 2007, Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory, Int. J. Pharm., 337, 118, 10.1016/j.ijpharm.2006.12.037
Raman, 2005, Modeling small-molecule release from PLG microspheres: Effects of polymer degradation and nonuniform drug distribution, J. Control. Release, 103, 149, 10.1016/j.jconrel.2004.11.012